Provided by Tiger Trade Technology Pte. Ltd.

Spero Therapeutics Inc.

1.22
+0.02001.67%
Post-market: 1.220.0040+0.33%19:30 EDT
Volume:338.47K
Turnover:411.23K
Market Cap:71.05M
PE:9.55
High:1.23
Open:1.20
Low:1.20
Close:1.20
52wk High:3.08
52wk Low:1.08
Shares:58.23M
Float Shares:45.59M
Volume Ratio:0.84
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1278
EPS(LYR):0.1500
ROE:19.17%
ROA:7.19%
PB:1.61
PE(LYR):8.13

Loading ...

Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 20, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 08, 2022

Major Issues Report

8-K - Current report
Oct 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 19, 2022

Major Issues Report

8-K - Current report